Lisa M Shulman1, Craig Velozo2, Sergio Romero3,4, Ann L Gruber-Baldini5. 1. Department of Neurology, University of Maryland School of Medicine, 110 S. Paca Street, Rm 3-S-127, Baltimore, MD, 21201-1559, USA. lshulman@som.umaryland.edu. 2. Division of Occupational Therapy, College of Health Professions, Medical University of South Carolina, Rm 330, 151-B Rutledge Avenue MSC 962, Charleston, SC, 29425-9620, USA. 3. Department of Occupational Therapy, University of Florida, Gainesville, FL, USA. 4. Department of Veterans Affairs, Center of Innovation on Disability and Rehabilitation Research, 1601 SW Archer Rd, Gainesville, FL, 32608, USA. 5. Division of Gerontology, Department of Epidemiology & Public Health, University of Maryland School of Medicine, Rm 213, Howard Hall, 660 West Redwood Street, Baltimore, MD, 21201-1559, USA.
Abstract
PURPOSE: Self-efficacy (SE) for managing chronic conditions is the belief that one can carry out behaviors to reach health goals. The study objective is to investigate (1) SE for managing chronic conditions across diverse neurologic conditions, (2) demographic and disease determinants of SE, and (3) SE as a predictor of health and disability. METHODS: Patients with chronic neurologic conditions (epilepsy, multiple sclerosis, neuropathy, Parkinson disease, stroke; n = 834) completed five SE for Managing Chronic Conditions instruments (Patient-Reported Outcomes Measurement Information System®; PROMIS®). Other assessments included PROMIS depression, fatigue, physical function, and global health. RESULTS: Two of the five SE domains showed differences across the five disorders (ANOVA; SE for Managing Daily Activities p < .001 and Managing Symptoms p < .01). The three domains with no differences were Managing Medications/Treatments, Emotions, and Social Interactions. Lowest SE was in neuropathy, and highest in epilepsy (Managing Activities) and stroke (Managing Symptoms). Multivariate regression showed SE measures to be better predictors of mental health, global health, and disability than either disease severity or diagnosis. CONCLUSIONS: SE for managing chronic conditions differs across neurologic disorders, with lowest SE for managing activities and symptoms in neuropathy, and highest in patients with epilepsy and stroke. PROMIS SE measures are better predictors of mental health, disability, and quality of life than disease severity or diagnosis.
PURPOSE: Self-efficacy (SE) for managing chronic conditions is the belief that one can carry out behaviors to reach health goals. The study objective is to investigate (1) SE for managing chronic conditions across diverse neurologic conditions, (2) demographic and disease determinants of SE, and (3) SE as a predictor of health and disability. METHODS:Patients with chronic neurologic conditions (epilepsy, multiple sclerosis, neuropathy, Parkinson disease, stroke; n = 834) completed five SE for Managing Chronic Conditions instruments (Patient-Reported Outcomes Measurement Information System®; PROMIS®). Other assessments included PROMIS depression, fatigue, physical function, and global health. RESULTS: Two of the five SE domains showed differences across the five disorders (ANOVA; SE for Managing Daily Activities p < .001 and Managing Symptoms p < .01). The three domains with no differences were Managing Medications/Treatments, Emotions, and Social Interactions. Lowest SE was in neuropathy, and highest in epilepsy (Managing Activities) and stroke (Managing Symptoms). Multivariate regression showed SE measures to be better predictors of mental health, global health, and disability than either disease severity or diagnosis. CONCLUSIONS: SE for managing chronic conditions differs across neurologic disorders, with lowest SE for managing activities and symptoms in neuropathy, and highest in patients with epilepsy and stroke. PROMIS SE measures are better predictors of mental health, disability, and quality of life than disease severity or diagnosis.
Authors: Rosemarie Arnold; Adelita V Ranchor; Mike J L DeJongste; Gerard H Köeter; Nick H T Ten Hacken; René Aalbers; Robbert Sanderman Journal: Behav Med Date: 2005 Impact factor: 3.104
Authors: Erin E Ross; Rachel A Colbath; Jeremy Yu; Naikhoba Munabi; T Justin Gillenwater; Haig A Yenikomshian Journal: J Burn Care Res Date: 2022-09-01 Impact factor: 1.819
Authors: Henk J Arwert; Daniella M Oosterveer; Jan W Schoones; Caroline B Terwee; Thea P M Vliet Vlieland Journal: Arch Rehabil Res Clin Transl Date: 2022-03-25
Authors: Tom P M M Vluggen; Jolanda C M van Haastregt; Jeanine A Verbunt; Caroline M van Heugten; Jos M G A Schols Journal: BMC Neurol Date: 2020-05-29 Impact factor: 2.474